Connect with us

Food & Drinks

Deloitte Predicts $2.7 Billion on Canada’s Alternative Cannabis Products Market



Deloitte Estimates $2.7 Billion on Canada’s Alternative Cannabis Products Market

The cannabis industry in Canada is projected to get a big boost with edibles and other derivatives becoming legal coming October. Based on a new Deloitte report, the worth of this new segment will be approximately $2.7 billion. Edibles will account for more than half of this amount.

While recreational cannabis has been legal for about 8 months, edibles and other cannabis derivatives have remained illegal all through since Health Canada required more time to make risk assessments and prepare for their rollout.

A survey of 2000 Canadians made by Deloitte suggests a breakdown of different components within the market of derivatives as follows.

  • Cannabis infused edibles: $1.6 billion
  • Beverages infused with cannabis: $529 million
  • Infused topicals: $174 million
  • Cannabis Concentrates: $140 million
  • Infused Tinctures: $116 million
  • Cannabis Capsules: $114 million

The wider assortment of cbd-infused products waiting to be made legal this fall are highlighted in the edibles category, which will become the most popular. In more mature US legal markets, cannabis-infused gummy bears and chocolate have proven to be an incredible hit and are anticipated to appeal to Canada’s broader audience.

About half of potential edible users polled by Deloitte held that they would prefer cookies, gummies, and chocolate at least one time for every three months.

Remarkable Opportunities Ahead

The launch of the edibles market will create doors for investors to carve market share early on. OrganiGram Holdings intends to position itself as cannabis-infused chocolate leader, while companies such as Canopy Growth Corp are looking to bank on the popularity of cannabis-infused beverages.

However, Deloitte has pointed out that not all companies are going to do well. According to Jennifer Lee, the National Leader for Deloitte in Canada, only the cannabis companies that have strong professional leadership, a focused strategy, business fundamentals, willingness place bets, and readiness to wait out changing regulatory environments will prosper in the industry.

Global Market Expected to Hit US$194 Billion

Despite the impressive Canadian market’s projected value, Deloitte anticipates that in 5 years, alternative cannabis product’s demand will hit US$194 billion. The growth and opportunities are expected throughout the world, but most of this growth is likely to come from North America and the U.S. in particular.

As cannabis gets legalized in more U.S. states, a significant potential for edibles will be uncovered. In Canada, the soon-to-be edibles market will benefit many companies with some organic growth. However, this will be a drop in the ocean when compared to the U.S. market’s potential if the cannabis legalization in more states continues.

Otto Baynes, a self-titled ‘great researcher’ with a Bachelor's Degree in Journalism, Linguistics, and Sociology, is one of the main core contributors at TOC to deliver daily news and fresh takeaways. It becomes very evident when consuming his cleverly-crafted content that his avid health and nutrition research skills are top shelf and are on full display. Watch Otto closely as Mr. Baynes plans to keep a pulse on the rapidly-evolving hemp and CBD industries.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.